• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Cytotheryx

Monday, June 03, 2024
CP
Platform for Therapeutics
Cytotheryx is a platform technology company focused on the development of a consistent, high-quality source of primary human hepatocytes, or liver cells, to address the critical shortage of these cells currently available. The proprietary technology was originally developed at, and licensed from, the Mayo Clinic in Rochester, MN.
Cytotheryx
Company Website: http://www.cytotheryx.com
Lead Product in Development: Human Primary Hepatocytes

Company HQ City

Rochester

Company HQ State

Minnesota

Company HQ Country

United States

CEO/Top Company Official

John Swart, PhD

Development Phase of Primary Product

Discovery
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS